Literature DB >> 20089001

Laboratory findings in CD4(+) large granular lymphocytoses.

H Olteanu1, N J Karandikar, C Eshoa, S H Kroft.   

Abstract

Large granular lymphocytic (LGL) leukemia is an uncommon disorder of mature T or natural killer (NK) cells. Most T-LGL proliferations are CD3(+)/CD8(+), although rare CD4(+) clonal T-LGL expansions have been reported. We report the clinicopathologic features of eight patients with aberrant CD4(+), cytotoxic T-cell lymphocytoses. Median follow-up was 29 months (range 8-100), during which all were alive without requirement for therapy. Four of eight patients had an additional malignancy; none had a history of rheumatoid arthritis, lymphadenopathy or hepatosplenomegaly. Morphologic expansions of granulated lymphocytes were evident in 6/8. All had immunophenotypically aberrant populations of CD4(+) T cells with uniform, moderate or bright CD56. Seven of eight expressed CD57, and four were CD8(partial dim +). Abnormal levels of expression of two or more T-cell antigens were seen in all cases. All tested cases were Tgamma PCR positive. Our results support that CD4(+) T-LGL lymphocytosis is a clonal disorder with clinicopathologic characteristics distinct from the more common CD8(+) variant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20089001     DOI: 10.1111/j.1751-553X.2008.01109.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  7 in total

1.  Monoclonal B-cell lymphocytosis (MBL, CD4+/CD8 weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders.

Authors:  Daniel Mazza Matos; Ana Cesarina Vitoriano de Oliveira; Maria de Nazaré Amaral Tomé; Carlos Alberto Scrideli
Journal:  Med Oncol       Date:  2012-06-12       Impact factor: 3.064

2.  High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Authors:  Emma I Andersson; Takahiro Tanahashi; Nodoka Sekiguchi; Vanessa Rebecca Gasparini; Sabrina Bortoluzzi; Toru Kawakami; Kazuyuki Matsuda; Takeki Mitsui; Samuli Eldfors; Stefania Bortoluzzi; Alessandro Coppe; Andrea Binatti; Sonja Lagström; Pekka Ellonen; Noriyasu Fukushima; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Hideyuki Nakazawa; Yok-Lam Kwong; Thomas P Loughran; Jaroslaw P Maciejewski; Satu Mustjoki; Fumihiro Ishida
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

3.  T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics.

Authors:  Min Shi; Horatiu Olteanu; Dragan Jevremovic; Rong He; David Viswanatha; Heidi Corley; Pedro Horna
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

4.  A towards-multidimensional screening approach to predict candidate genes of rheumatoid arthritis based on SNP, structural and functional annotations.

Authors:  Liangcai Zhang; Wan Li; Leilei Song; Lina Chen
Journal:  BMC Med Genomics       Date:  2010-08-20       Impact factor: 3.063

5.  Asymptomatic T-cell large granular lymphocyte leukemia with an unusual immunophenotype.

Authors:  Panagiota K Petsa; Achilleas Karamoutsios; Lefkothea Dova; Leonidas Benetatos; Asimina Petsiou; Nikolaos Kolaitis; Antonis Georgopoulos; Georgios Vartholomatos
Journal:  Clin Pract       Date:  2012-06-27

Review 6.  Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies.

Authors:  Pedro Horna; Min Shi; Horatiu Olteanu; Ulrika Johansson
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

7.  A case of CD4(+)T-cell large granular lymphocytic leukemia.

Authors:  Jaewook Kim; Chan Jeoung Park; Seongsoo Jang; Young-Uk Cho; Sang Hyuk Park; Eul-Ju Seo; Hyun-Sook Chi; Cheolwon Suh
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.